[A case of Guillain-Barré syndrome with unilateral diaphragmatic nerve palsy that was longitudinally evaluated using multiple examinations]

Rinsho Shinkeigaku. 2022 Oct 22;62(10):805-809. doi: 10.5692/clinicalneurol.cn-001765. Epub 2022 Sep 30.
[Article in Japanese]

Abstract

The patient, a 50-year-old woman, presented with fever and diarrhea in early July, X. One week later, she noticed muscle weakness in both lower extremities, which upon examination was found to be dominant in the distal muscles, with associated loss of tendon reflexes. We diagnosed the case as Guillain-Barré syndrome. After admission, the patient experienced decreased oxygenation, and a chest X-ray indicated elevation of the left hemidiaphragm. The phrenic nerve conduction studies revealed laterality of the amplitude of compound muscle action potential, and diaphragmatic ultrasonographic examination revealed decreased left diaphragmatic wall motion. We diagnosed the patient with unilateral diaphragmatic nerve palsy and initiated intravenous immunoglobulin and methylprednisolone treatment. After 2 weeks, the patient demonstrated good clinical recovery, increased diaphragmatic nerve amplitude, and improved diaphragmatic movement. We evaluated the longitudinal clinical course of unilateral diaphragmatic nerve palsy in the patient using nerve conduction tests and diaphragmatic echocardiography. The longitudinal evaluation allowed us to assess the pathological condition more sensitively so that the prognosis could be predicted accurately.

Keywords: Guillain–Barré syndrome; diaphragmatic ultrasound examination; nerve conduction study; phrenic nerve palsy.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Female
  • Guillain-Barre Syndrome* / complications
  • Guillain-Barre Syndrome* / diagnosis
  • Guillain-Barre Syndrome* / drug therapy
  • Humans
  • Immunoglobulins, Intravenous* / therapeutic use
  • Methylprednisolone
  • Middle Aged
  • Paralysis / complications
  • Phrenic Nerve

Substances

  • Immunoglobulins, Intravenous
  • Methylprednisolone